🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Italy / NCT07426328
Enrolling by invitation Not applicable

Promoting Motivation and Linguage in Developmental Language Disorder Through Interaction With the Humanoid Social Robot

NCT07426328 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2025-02-01
Last updated
2026-02-23

Condition(s) studied

Development Language Disorder

Investigational drug(s) / intervention(s)

Nao assisted therapyStandard therapeutic protocol

Nao assisted therapy: The sessions included tasks designed to engage children in verbal and social interactions (e.g., naming objects, responding to questions, performing gestures). The NAO robot provided consistent and predictable feedback, while therapists supported and reinforced appropriate communicative behaviors.

Standard therapeutic protocol: The therapy included exercises aimed at improving verbal communication and social engagement (e.g., naming objects, sentence construction, and comprehension tasks). Therapists adjusted the intervention to match each child's communication goals.

Study summary

Developmental Language Disorder (DLD) is a communication disorder that interferes with learning, understanding, and using language. This pilot study investigates the use of the humanoid robot NAO as part of a rehabilitative program designed for children with DLD. NAO, with its predictable and engaging interaction style, is hypothesized to enhance communicative initiative, expressive communication, and social interaction in this population. The study employs a randomized controlled trial design, assigning participants to either a NAO-assisted intervention group or a control group receiving standard therapy. Outcomes will be assessed using standardized measures of communication, motivation, and observational data. This research aims to explore the potential of social robots as an innovative tool for addressing the unique needs of individuals with DLD, contributing to the development of effective, accessible therapeutic options that improve their quality of life and that of their families.

Eligibility

Sex
ALL
Min age
4 Years
Max age
5 Years
Healthy volunteers
No
Inclusion Criteria: * Developmental language disorder * Age between 4 and 5 years. Exclusion Criteria: * Presence of severe intellectual disability. * Diagnosis of neurological disorders. * Significant medical conditions that could interfere with study participation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
IRCCS Neurolesi Bonino Pulejo, Messina, Messina Messina

More IRCCS Centro Neurolesi Bonino Pulejo trials in Italy

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07426328 on ClinicalTrials.gov ↗ ← All trials in Italy